Retinal embolic events: frequency and impact following transcatheter aortic valve implantation (TAVI) for aortic stenosis
نویسندگان
چکیده
Objectives Transcatheter aortic valve implantation (TAVI) is an established treatment for patients with severe symptomatic aortic stenosis. It has a cerebrovascular accident rate of about 5% but the effect on retinal embolic events has not been previously reported. This study investigated the occurrence of retinal emboli following TAVI. Methods and analysis In this prospective observational study, 20 patients underwent full ophthalmic examination to assess retinal embolic events prior to TAVI and at 48 hours and 1 month post-TAVI. Results At 48 hours post-TAVI, one patient had a new cotton wool spot in the right eye. At 1 month, another two patients had new retinal emboli events in at least one eye and a fourth patient developed retinal splinter haemorrhages in the right eye. Conclusion Retinal embolic events and new retinal abnormalities following TAVI occurred in 15% and 20% of our cohort, respectively, without any associated retinal damage or significant visual problems. Retinal evaluation may be a useful surrogate test for cerebral embolisation in future studies assessing the utility of new valve prostheses and embolic protection devices.
منابع مشابه
Difference between cerebral embolic events following Transcatheter Aortic Valve Implantation (TAVI) and Surgical Aortic Valve Replacement (SAVR): a diffusion weighted MRI study
Background Transcatheter Aortic Valve Implantation (TAVI) is used to treat symptomatic severe aortic stenosis in a non-surgical high risk population. The incidence of stroke and micro-infarction is higher in the TAVI population compared to surgical aortic valve replacement (SAVR) at 30 days, which may be due to various factors such as valve calcification and aortic atheroma. However, the natura...
متن کاملIncidence and Prevention of Strokes in TAVI
Transcatheter aortic valve implantation (TAVI) is now a widely adopted option for many inoperable and high risk patients with severe aortic valve stenosis, and clinical trials continue to show great benefit with regards to mortality and major cardiovascular endpoints. As the technology continues to expand and possibly grow to include intermediate and low risk populations, investigators have rem...
متن کاملTrans-catheter Bioprosthetic Heart Valve Implantation in Iran (Tehran Heart Centre Experience)
Introduction: With the development of interventional cardiology in the world, in addition to coronary and aortic diseases, the treatment of heart valve diseases through catheters has recently begun. The treatment of aortic stenosis (which was only possible with open surgery and valve replacement) was first performed in the world in 2002 by Alain Cribier in France with catheter insertion of the ...
متن کاملLeft ventricular remodeling after transcatheter aortic valve implantation (TAVI)
Background Transcatheter aortic valve implantation (TAVI) offers a minimal invasive option for the treatment of patients with severe aortic stenosis at high risk for conventional surgery. The objective of this study was to investigate whether there is a positive effect on the left ventricular remodeling 6 month after transcatheter aortic valve implantation (TAVI) using cardiac magnetic resonanc...
متن کاملCerebrovascular accidents complicating transcatheter aortic valve implantation: frequency, timing and impact on outcomes.
AIMS Cerebrovascular accidents (CVA) are considered among the most serious adverse events after transcatheter aortic valve implantation (TAVI). The objective of the present study was to evaluate the frequency and timing of CVA after TAVI and to investigate the impact on clinical outcomes within 30 days of the procedure. METHODS AND RESULTS Between August 2007 and October 2011, 389 high-risk e...
متن کامل